OXT and pulmonary arterial hypertension: The deterministic sensitivity analysis findings showed the base-case cost-effectiveness results of PPH prevention with carbetocin to be highly robust, with threshold value identified for one influential factor (relative risk of PPH ≥500 mL with carbetocin versus oxytocin).